After Gajendra Singh, MD, was quoted $1,200 for an ultrasound at his local hospital’s outpatient department, he decided to open his own low-cost imaging center in Winston-Salem, North Carolina. But that’s where his problems began, Vox reported.

New research from the Massachusetts Institute of Technology (MIT) suggests a physician's intuition—or, in other words, gut feeling—about a patient’s condition significantly influences the amount of diagnostic imaging, which is well above the capabilities of artificial intelligence (AI).

Advanced imaging techniques have shown great potential in improving diagnosis and treatment of various conditions. But a recent study of patients undergoing breast augmentation surgery showed 3D image simulation did not improve satisfaction post-procedure, though most patients preferred the use of the imaging technique.

As the saying goes, You can’t always believe what you hear. But when it comes to patients self-reporting health care utilization, just how accurate can people be? A study, published July 30 in the Journal of Medical Internet Research, examined patients’ abilities to recall complications in the 90 days after orthopedic procedures through an automated online patient engagement survey.

Memories aren’t the perfect carbon copies of reality many people believe them to be. One person’s interpretation of an event could be quite different from another participant. Researchers hoped to limit communication breakdowns between nurses and physicians by recording video of interactions, so the participants could review and critique them.

Performing a cost-effectiveness analysis (CEA) is a crucial part of the decision-making process for any imaging provider. The industry lacks consistency when it comes to exactly how CEAs are carried out, however, which can make their conclusions less reliable.

The FDA approved the FreeStyle Libre flash glucose monitoring system, which works for up to 14 days at a time, according to an announcement from device maker Abbott.

Fujifilm’s Aspire Cristalle breast imaging system violates four patents owned by Hologic, according to the initial ruling on July 26 of U.S. International Trade Commission Judge Clark Cheney.